| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bb2c65fed767c6cdb08ca3b49dbb9f0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 |
| filingDate |
2005-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9051b9c81c7d8ec9bd7cd4978a99d3b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7210140bc77f40bbbb257f1822d28d00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87dab5654d8452f8881ab3fa598269e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd9a6d04929edd22cd40f04497915d3b |
| publicationDate |
2009-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7569580-B2 |
| titleOfInvention |
Heterotricyclic compounds for use as HCV inhibitors |
| abstract |
The present invention comprises tetrazoloquinoline-compounds that are inhibitors of HCV. Compositions comprising the compounds in combination with a pharmaceutically acceptable carrier are also disclosed, as are methods of using the compounds and compositions to inhibit HCV infection of a cell, particular in the form of treating HCV infection in a mammal. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11236103-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7943635-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10927104-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008255191-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10513515-B2 |
| priorityDate |
2004-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |